Yüklüyor......
Preclinical Evaluation of (203/212)Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate Cancer
Targeted radiopharmaceutical therapy (TRT) using α-particle radiation is a promising approach for treating both large and micrometastatic lesions. We developed prostate-specific membrane antigen (PSMA)–targeted low-molecular-weight agents for (212)Pb-based TRT of patients with prostate cancer (PC) b...
Kaydedildi:
| Yayımlandı: | J Nucl Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Society of Nuclear Medicine
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6954458/ https://ncbi.nlm.nih.gov/pubmed/31253744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.119.229393 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|